Director Ye Changqing Updates Holdings Disclosure for Ascentage Pharma
ASCENTAGE PHARMA GROUP INTERNATIONAL
Subscribe to track AAPG
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Director Ye Changqing Updates Holdings Disclosure for Ascentage Pharma
Company: ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) Form: 3/A (Amendment) | Filed: 2026-03-23 Significance: Low
Insider: Ye Changqing Title: Director | Relationship: Director
Transaction Details: • Type: Holdings Correction (Initial Statement) • Shares Owned: 8,964 (Ordinary Shares) • Derivatives: 18,850 Options ($8.14 strike) + 28,850 RSUs • Note: Filing corrects previously omitted holdings.
Key Insight: Administrative amendment to correct inadvertent omissions in the original Form 3 submission. Represents <0.02% of outstanding shares.
Market Context: Ascentage Pharma is a $16.35B biotech company. This filing is a compliance cleanup and does not indicate active trading sentiment.
Comprehensive Analysis
SEC Filing Analysis: ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
Executive Summary
- Trading Significance: Low
- Key Takeaway: Director Ye Changqing filed an amendment to disclose share and derivative holdings previously omitted from the original Form 3.
- Market Impact: Neutral. This is an administrative correction with no active trading implications.
Company Information
| Field | Value |
|---|---|
| Company | ASCENTAGE PHARMA GROUP INTERNATIONAL |
| Ticker Symbol | AAPG |
| CIK | 0002023311 |
| Market Cap | $16.35 Billion |
| Shares Outstanding | 373,320,000 |
Insider Information
| Field | Value |
|---|---|
| Name | Ye Changqing |
| CIK | 0001968607 |
| Title/Position | Director |
| Relationship | Director |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 3/A (Initial Statement Amendment) |
| Transaction Date | N/A (Holdings Snapshot) |
| Security Type | Ordinary Shares, Options, RSUs |
| Shares Owned (Direct) | 8,964 |
| Options Held | 18,850 (Strike: $8.14) |
| RSUs Held | 28,850 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Total Holdings Disclosed | 56,664 shares (including derivatives) |
| % of Shares Outstanding | ~0.015% |
| Implied Value of Holdings | ~$2.48 Million (Est. based on Market Cap/Share) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: With a market capitalization of $16.35 billion, the disclosed holdings (~$2.5M value) represent a negligible fraction of the company's equity.
- Ownership Concentration: The insider holds approximately 0.015% of the company on a fully diluted basis, indicating a minor minority stake.
- Transaction Significance: This is a Form 3/A, which is a retrospective report of ownership, not a real-time buy or sell signal. The footnotes indicate these securities were "inadvertently not reported in the original submission."
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The filing is purely administrative to fix a compliance error. No shares were bought or sold on the open market, and the total ownership percentage is too small to influence the stock price.
Volume & Sentiment
- Expected Volume Impact: None.
- Sentiment Indicator: Neutral.
Additional Context
Transaction Notes
- Correction Details: The filing explicitly states that the number of Ordinary Shares, Share Options, and vesting schedules were incorrectly reported or omitted in the original submission.
- Vesting: The options vest monthly starting Nov 2025; RSUs vest annually starting Nov 2026.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.